Comparison between the antiproteinuric effects of the calcium channel blockers benidipine and cilnidipine in combination with angiotensin receptor blockers in hypertensive patients with chronic kidney disease

Expert Opinion on Investigational Drugs
M AbeMasayoshi Soma

Abstract

Benidipine, an L-/T-type calcium channel blocker, dilates renal efferent and afferent arterioles and reduces glomerular pressure; therefore, it may exert renoprotective effects. We conducted an open-labeled randomized trial to compare the effects of benidipine with cilnidipine in hypertensive patients with chronic kidney disease (CKD). The patients who were already being treated with angiotensin receptor blockers (ARBs) received one of the following treatment regimens: benidipine at a dose of 2 mg/day that was increased up to a dose of 8 mg/day (benidipine group; n=118) or cilnidipine at a dose of 5 mg/day that was increased up to a dose of 20 mg/day (cilnidipine group; n=115). After 12 months of treatment, we observed a significant and comparable reduction in the systolic and diastolic blood pressure in both groups. The urinary protein:creatinine ratio was significantly decreased in both groups after 3 months of treatment and thereafter; however, the difference between both groups was not significant after 12 months of treatment. Benidipine exerted an antiproteinuric effect to a greater extent than cilnidipine in patients with diabetes. The addition of benidipine as well as cilnidipine reduces urinary protein excretion in hype...Continue Reading

References

Jul 17, 1999·European Journal of Pharmacology·H UneyamaN Akaike
Apr 25, 2000·Neuron·E A ErtelW A Catterall
Oct 14, 2000·Annual Review of Cell and Developmental Biology·W A Catterall
Aug 21, 2001·Hypertension Research : Official Journal of the Japanese Society of Hypertension·G W RoseH Suzuki
Aug 21, 2001·Hypertension Research : Official Journal of the Japanese Society of Hypertension·W YueY Abe
Sep 22, 2001·The New England Journal of Medicine·E J LewisUNKNOWN Collaborative Study Group
Dec 1, 2001·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·G D LavermanD de Zeeuw
Aug 7, 2002·Circulation·Giancarlo VibertiUNKNOWN MicroAlbuminuria Reduction With VALsartan (MARVAL) Study Investigators
Oct 3, 2002·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Takashi MorikawaMasahito Imanishi
Nov 21, 2002·JAMA : the Journal of the American Medical Association·Jackson T WrightUNKNOWN African American Study of Kidney Disease and Hypertension Study Group
May 16, 2003·JAMA : the Journal of the American Medical Association·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee
May 19, 2004·Fundamental & Clinical Pharmacology·Alexander NapPieter A van Zwieten
Jul 16, 2004·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Shunichi KojimaHiroyuki Yokoyama
Aug 17, 2004·Neuroscience Letters·Manabu MurakamiToshihiko Iijima
Nov 19, 2005·Journal of Pharmacological Sciences·Koichi HayashiTakao Saruta
Dec 13, 2005·Kidney International. Supplement·Rafael MarínRafael Alvarez-Navascués
May 26, 2006·Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension·Bernard Waeber
Feb 20, 2007·Circulation Research·Koichi HayashiTakao Saruta
Sep 6, 2007·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Toshihiko IshimitsuHiroaki Matsuoka
Oct 19, 2007·Kidney International·T FujitaUNKNOWN Cilnidipine versus Amlodipine Randomised Trial for Evaluation in Renal Desease(CARTER) Study Investigators
Nov 27, 2007·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Mitsuru OhishiToshio Ogihara
Mar 21, 2008·Kidney International·G L BakrisUNKNOWN GUARD (Gauging Albuminuria Reduction With Lotrel in Diabetic Patients With Hypertension) Study Investigators
Apr 3, 2009·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Seiichi MatsuoUNKNOWN Collaborators developing the Japanese equation for estimated GFR
Feb 4, 2010·JAMA : the Journal of the American Medical Association·Brenda R HemmelgarnUNKNOWN Alberta Kidney Disease Network

❮ Previous
Next ❯

Citations

Jul 15, 2011·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Koichi Hayashi
Jun 9, 2011·Clinical and Experimental Hypertension : CHE·Hiroaki MatsuokaUNKNOWN SAKURA Trial Investigators
Jul 15, 2016·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Nicolás R RoblesGuido Grassi
Aug 16, 2016·Bioscience Reports·Tadashi KonoshitaUNKNOWN Genomic Disease Outcome Consortium (G-DOC) Study Investigators

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.